Background: Osteopontin (OPN) is a proinflammatory biomarker, and neurofilament light chain (NFL) levels reflect axonal damage. Resting-state functional MRI (rs-fMRI) defines brain networks during wakeful rest. Objective: To examine, if levels of OPN and NFL are associated on the long term with (i) lesion evolution, (ii) changes in normal-appearing white matter (NAWM) microstructure and (iii) functional connectivity in multiple sclerosis (MS). Methods: Concentration of NFL and OPN in the blood and CSF were related to MRI findings 10.3 ± 2.8 years later in 53 patients with MS. NFL was examined by Simoa method, OPN by ELISA. Lesion volume in the brain and cervical spinal cord was examined by 3D FLAIR images. Voxel-wise images of fractional an...
Altres ajuts: T Jens Kuhle was supported by an ECTRIMS Research Fellowship Programme and by the Fors...
BACKGROUND: Neurofilament light chain (NfL) represents a promising biomarker for axonal injury. We p...
BACKGROUND AND OBJECTIVES: The specificity of novel blood biomarkers for multiple sclerosis (MS)-rel...
BACKGROUND: Brain atrophy is a known marker of irreversible tissue damage in multiple sclerosis (MS...
BACKGROUND AND OBJECTIVES: To investigate whether white matter lesion activity, acute axonal damage,...
Objective: To assess whether chronic white matter inflammation in patients with multiple sclerosis (...
Background: There is a need for clinically useful biomarkers of disease activity in clinically isola...
Neurofilaments are neuronal-specific proteins involved in neuroaxonal functions like determining axo...
markdownabstract__Background:__ A promising biomarker for axonal damage early in the disease course ...
Background: The predictive value of serum neurofilament light chain (sNfL) on long-term prognosis in...
Background: Serum neurofilament light (sNfL) chain is a promising biomarker reflecting neuro-axonal...
A major aim in MS field has been the search for biomarkers that enable accurate detection of neurona...
Background: Brain functional connectivity (FC) in multiple sclerosis (MS) is abnormal compared to h...
Background and Objectives Connectivity-based approaches incorporating the distribution and magnitud...
BACKGROUND: Neurofilaments are promising biomarkers in multiple sclerosis (MS) and increased levels ...
Altres ajuts: T Jens Kuhle was supported by an ECTRIMS Research Fellowship Programme and by the Fors...
BACKGROUND: Neurofilament light chain (NfL) represents a promising biomarker for axonal injury. We p...
BACKGROUND AND OBJECTIVES: The specificity of novel blood biomarkers for multiple sclerosis (MS)-rel...
BACKGROUND: Brain atrophy is a known marker of irreversible tissue damage in multiple sclerosis (MS...
BACKGROUND AND OBJECTIVES: To investigate whether white matter lesion activity, acute axonal damage,...
Objective: To assess whether chronic white matter inflammation in patients with multiple sclerosis (...
Background: There is a need for clinically useful biomarkers of disease activity in clinically isola...
Neurofilaments are neuronal-specific proteins involved in neuroaxonal functions like determining axo...
markdownabstract__Background:__ A promising biomarker for axonal damage early in the disease course ...
Background: The predictive value of serum neurofilament light chain (sNfL) on long-term prognosis in...
Background: Serum neurofilament light (sNfL) chain is a promising biomarker reflecting neuro-axonal...
A major aim in MS field has been the search for biomarkers that enable accurate detection of neurona...
Background: Brain functional connectivity (FC) in multiple sclerosis (MS) is abnormal compared to h...
Background and Objectives Connectivity-based approaches incorporating the distribution and magnitud...
BACKGROUND: Neurofilaments are promising biomarkers in multiple sclerosis (MS) and increased levels ...
Altres ajuts: T Jens Kuhle was supported by an ECTRIMS Research Fellowship Programme and by the Fors...
BACKGROUND: Neurofilament light chain (NfL) represents a promising biomarker for axonal injury. We p...
BACKGROUND AND OBJECTIVES: The specificity of novel blood biomarkers for multiple sclerosis (MS)-rel...